Template:Available_forms_of_progesterone
Template:Available forms of progesterone
More information Route, Form ...
Route | Form | Dose | Brand name | Availability[lower-alpha 2] |
---|---|---|---|---|
Oral | Capsule | 100, 200, 300 mg | Prometrium[lower-alpha 3] | Widespread |
Tablet (SR) | 200, 300, 400 mg | Dubagest SR[lower-alpha 3] | India | |
Sublingual | Tablet | 10, 25, 50, 100 mg | Luteina[lower-alpha 3] | Europe[lower-alpha 4] |
Transdermal | Gel[lower-alpha 5] | 1% (25 mg) | Progestogel | Europe |
Vaginal | Capsule | 100, 200 mg | Utrogestan | Widespread |
Tablet | 100 mg | Endometrin[lower-alpha 3] | Widespread | |
Gel | 4, 8% (45, 90 mg) | Crinone[lower-alpha 3] | Widespread | |
Suppository | 200, 400 mg | Cyclogest | Europe | |
Ring | 10 mg/day[lower-alpha 6] | Fertiring[lower-alpha 3] | South America[lower-alpha 7] | |
Rectal | Suppository | 200, 400 mg | Cyclogest | Europe |
Uterine | IUD | 38 mg | Progestasert | Discontinued |
Intramuscular injection |
Oil solution | 2, 5, 10, 20, 25, 50, 100 mg/mL | Proluton[lower-alpha 3] | Widespread |
Aq. susp. | 12.5, 30, 100 mg/mL | Agolutin[lower-alpha 3] | Europe[lower-alpha 8] | |
Emulsion | 5, 10, 25 mg/mL | Di-Pro-Emulsion | Discontinued | |
Microsph. | 20, 100 mg/mL | ProSphere[lower-alpha 3] | Mexico | |
Subcutaneous | Aq. soln. (inj.) | 25 mg/vial | Prolutex | Europe |
Implant | 50, 100 mg | Proluton[lower-alpha 3] | Discontinued | |
Intravenous | Aq. soln. (inj.) | 20 mg/mL | Primolut | Discontinued |
Sources and footnotes:
|
Close
Template documentation
See also
References
- "Drugs@FDA: FDA Approved Drug Products". United States Food and Drug Administration. Retrieved 26 July 2018.
- Engel J, Kleemann A, Kutscher B, Reichert D (14 May 2014). Pharmaceutical Substances, 5th Edition, 2009: Syntheses, Patents and Applications of the most relevant APIs. Thieme. pp. 1145–. ISBN 978-3-13-179275-4.
- Becker KL (2001). Principles and Practice of Endocrinology and Metabolism. Lippincott Williams & Wilkins. pp. 2168–. ISBN 978-0-7817-1750-2.
- Anita MV, Jain S, Goel N (31 July 2018). Use of Progestogens in Clinical Practice of Obstetrics and Gynecology. JP Medical Ltd. pp. 4–. ISBN 978-93-5270-218-3.
- Sauer MV (1 March 2013). Principles of Oocyte and Embryo Donation. Springer Science & Business Media. pp. 7, 117–118. ISBN 978-1-4471-2392-7.
- Elder K, Dale B (2 December 2010). In-Vitro Fertilization. Cambridge University Press. pp. 26–. ISBN 978-1-139-49285-0.
- "PROSPHERE CARNOT". Archived from the original on 2019-12-30.
- Heinrich Kahr (8 March 2013). Konservative Therapie der Frauenkrankheiten: Anzeigen, Grenzen und Methoden Einschliesslich der Rezeptur. Springer-Verlag. pp. 21–. ISBN 978-3-7091-5694-0.
- Basic Sex Hormone Therapy. Schering A.G. 1962. p. 96.
- Current Medicine and Drugs. 1962. p. 40.
Primolut Intravenous (Schering A.G. Berlin)
Editors can experiment in this template's sandbox (create | mirror) and testcases (create) pages.
Subpages of this template.
Subpages of this template.